title: A woman with breast cancer and severe impaired lactose tolerance: an intriguing therapeutic dilemma.
authors.forename: Flora
authors.initials: F
authors.lastname: Zagouri
authors.forename: Constantine
authors.initials: C
authors.lastname: Dimitrakakis
authors.forename: Meletios-Athanassios
authors.initials: MA
authors.lastname: Dimopoulos
authors.forename: Alexandra
authors.initials: A
authors.lastname: Tsigginou
authors.forename: Aris
authors.initials: A
authors.lastname: Antsaklis
authors.forename: Christos A
authors.initials: CA
authors.lastname: Papadimitriou
mesh_terms: D000077384:Anastrozole; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects* / Q000627:therapeutic use; D047072:Aromatase Inhibitors / Q000009:adverse effects; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000532:radiotherapy; D018275:Carcinoma, Lobular / Q000188:drug therapy* / Q000473:pathology / Q000532:radiotherapy; D003967:Diarrhea / Q000139:chemically induced; D004958:Estradiol / Q000031:analogs & derivatives* / Q000627:therapeutic use; D005260:Female; D000077267:Fulvestrant; D006801:Humans; D007787:Lactose Intolerance; D008197:Lymph Node Excision; D008875:Middle Aged; D009570:Nitriles / Q000008:administration & dosage / Q000009:adverse effects; D013629:Tamoxifen / Q000008:administration & dosage / Q000009:adverse effects; D014230:Triazoles / Q000008:administration & dosage / Q000009:adverse effects
chemical_list: D018931:Antineoplastic Agents, Hormonal; D047072:Aromatase Inhibitors; D009570:Nitriles; D014230:Triazoles; D013629:Tamoxifen; D000077267:Fulvestrant; D000077384:Anastrozole; D004958:Estradiol